Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 2 2Phase EARLY_PHASE1 1

Status

Unknown 2Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Genitourinary 1Breast 1

Conditions

Liver Neoplasms 1Liver Cirrhosis 1Kidney Neoplasms 1Hepatitis B 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

pembrolizumab 223Carboplatin 222Specimen Handling 194Cisplatin 192Magnetic Resonance Spectroscopy 165Radiotherapy 153Bevacizumab 143Gemcitabine 136Cyclophosphamide 135Drug Therapy 119Capecitabine 118Paclitaxel 116Oxaliplatin 111Nivolumab 105Biopsy 104venetoclax 103tislelizumab 83Rituximab 83durvalumab 82toripalimab 78Fluorouracil 73Etoposide 72Docetaxel 69Dexamethasone 69sintilimab 67Pemetrexed 67atezolizumab 65Radiosurgery 65Azacitidine 63130-nm albumin-bound paclitaxel 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Ultrasonography × Clear all
NCT07225114 2026-01-06

Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging

UNC Lineberger Comprehensive Cancer Center

Phase 2 Recruiting
40 enrolled
BreastGastrointestinalGenitourinary

Breast Neoplasms, Kidney Neoplasms, Liver Neoplasms

NCT05304234 2024-06-04

Liver Cancer Disparities in American Indian and Alaska Native Persons

University of Washington

Phase 2 Recruiting
200 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡